Insulin inhibits IL-10-mediated regulatory T cell function: Implications for obesity

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 623-629

  Han, Jonathan M ^a   Patterson, Scott J ^a   Speck, Madeleine ^a   Ehses, Jan A ^a   Levings, Megan K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYPERINSULINEMIA; INTRAABDOMINAL FAT; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; APYRASE; CELLS, CULTURED; CTLA-4 ANTIGEN; EPITHELIAL CELLS; EPITHELIUM; HYPERINSULINISM; INFLAMMATION; INSULIN; INTERFERON-GAMMA; INTERLEUKIN-10; INTRA-ABDOMINAL FAT; MACROPHAGES; MICE; MICE, INBRED C57BL; OBESITY; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892721397     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302181     Document Type: Article

References (49)

1. Osborn, O., and J. M. Olefsky. 2012. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18: 363-374.
2. Donath, M. Y., and S. E. Shoelson. 2011. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11: 98-107.
3. Hirosumi, J., G. Tuncman, L. Chang, C. Z. Görgün, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336. (Pubitemid 35398190)
4. Yuan, M., N. Konstantopoulos, J. Lee, L. Hansen, Z. W. Li, M. Karin, and S. E. Shoelson. 2001. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673-1677. (Pubitemid 32807849)
5. Olefsky, J. M., and C. K. Glass. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72: 219-246.
6. Han, J. M., and M. K. Levings. 2013. Immune regulation in obesity-associated adipose inflammation. J. Immunol. 191: 527-532.
7. Winer, S., and D. A. Winer. 2012. The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance. Immunol. Cell Biol. 90: 755-762.
8. Deiuliis, J., Z. Shah, N. Shah, B. Needleman, D. Mikami, V. Narula, K. Perry, J. Hazey, T. Kampfrath, M. Kollengode, et al. 2011. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS ONE 6: e16376.
9. Feuerer, M., L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A. B. Goldfine, C. Benoist, S. Shoelson, and D. Mathis. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15: 930-939.
10. Winer, S., Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, F. Mastronardi, et al. 2009. Normalization of obesityassociated insulin resistance through immunotherapy. Nat. Med. 15: 921-929.
11. Jeanrenaud, B. 1978. Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology. Metabolism 27(12 Suppl. 2): 1881-1892. (Pubitemid 9082245)
12. Mehran, A. E., N. M. Templeman, G. S. Brigidi, G. E. Lim, K. Y. Chu, X. Hu, J. D. Botezelli, A. Asadi, B. G. Hoffman, T. J. Kieffer, et al. 2012. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 16: 723-737.
13. Cartee, G. D., and J. F. Wojtaszewski. 2007. Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl. Physiol. Nutr. Metab. 32: 557-566.
14. Han, J. M., S. J. Patterson, and M. K. Levings. 2012. The role of the PI3K signaling pathway in CD4(+) T cell differentiation and function. Front. Immunol. 3: 245.
15. Patterson, S. J., J. M. Han, R. Garcia, K. Assi, T. Gao, A. O'Neill, A. C. Newton, and M. K. Levings. 2011. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J. Immunol. 186: 5533-5537.
16. Bensinger, S. J., P. T. Walsh, J. Zhang, M. Carroll, R. Parsons, J. C. Rathmell, C. B. Thompson, M. A. Burchill, M. A. Farrar, and L. A. Turka. 2004. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172: 5287-5296. (Pubitemid 38542026)
17. Crellin, N. K., R. V. Garcia, and M. K. Levings. 2007. Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109: 2014-2022. (Pubitemid 46348201)
18. Haxhinasto, S., D. Mathis, and C. Benoist. 2008. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205: 565-574. (Pubitemid 351439304)
19. Lee, K., P. Gudapati, S. Dragovic, C. Spencer, S. Joyce, N. Killeen, M. A. Magnuson, and M. Boothby. 2010. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32: 743-753.
20. Delgoffe, G. M., K. N. Pollizzi, A. T. Waickman, E. Heikamp, D. J. Meyers, M. R. Horton, B. Xiao, P. F. Worley, and J. D. Powell. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12: 295-303.
21. Battaglia, M., A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M. G. Roncarolo. 2006. Rapamycin promotes expansion of functional CD4 +CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177: 8338-8347. (Pubitemid 44893795)
22. Gagliani, N., S. Gregori, T. Jofra, A. Valle, A. Stabilini, D. M. Rothstein, M. Atkinson, M. G. Roncarolo, and M. Battaglia. 2011. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS ONE 6: e28434.
23. Haribhai, D., W. Lin, L. M. Relland, N. Truong, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 178: 2961-2972. (Pubitemid 46333175)
24. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
25. Madan, R., F. Demircik, S. Surianarayanan, J. L. Allen, S. Divanovic, A. Trompette, N. Yogev, Y. Gu, M. Khodoun, D. Hildeman, et al. 2009. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183: 2312-2320.
26. Konrad, D., A. Rudich, and E. J. Schoenle. 2007. Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue. Diabetologia 50: 833-839. (Pubitemid 46355832)
27. Karam, J. H., G. M. Grodsky, and P. H. Forsham. 1965. The relationship of obesity and growth hormone to serum insulin levels. Ann. N. Y. Acad. Sci. 131: 374-387.
28. Wang, X., and C. G. Proud. 2006. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 21: 362-369. (Pubitemid 44511764)
29. Vignali, D. A. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
30. Kotzka, J., S. Lehr, G. Roth, H. Avci, B. Knebel, and D. Muller-Wieland. 2004. Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo. J. Biol. Chem. 279: 22404-22411. (Pubitemid 38679438)
31. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
32. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
33. Takahashi, T., Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh, M. Iwata, J. Shimizu, and S. Sakaguchi. 1998. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980. (Pubitemid 28566059)
34. Ehses, J. A., D. T. Meier, S. Wueest, J. Rytka, S. Boller, P. Y. Wielinga, A. Schraenen, K. Lemaire, S. Debray, L. Van Lommel, et al. 2010. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 53: 1795-1806.
35. Kahn, B. B., and J. S. Flier. 2000. Obesity and insulin resistance. J. Clin. Invest. 106: 473-481. (Pubitemid 30666380)
36. Stephens, J. M., J. Lee, and P. F. Pilch. 1997. Tumor necrosis factor-alphainduced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem. 272: 971-976. (Pubitemid 27034588)
37. Schmidt, A., N. Oberle, and P. H. Krammer. 2012. Molecular mechanisms of Treg-mediated T cell suppression. Front. Immunol. 3: 51.
38. Qin, A., Z. Wen, Y. Zhou, Y. Li, Y. Li, J. Luo, T. Ren, and L. Xu. 2013. MicroRNA-126 regulates the induction and function of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway. J. Cell. Mol. Med. 17: 252-264.
39. + regulatory T cells. Nat. Immunol. 14: 162-171.
40. Patton, D. T., O. A. Garden, W. P. Pearce, L. E. Clough, C. R. Monk, E. Leung, W. C. Rowan, S. Sancho, L. S. Walker, B. Vanhaesebroeck, and K. Okkenhaug. 2006. Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177: 6598-6602. (Pubitemid 44715022)
41. Wachstein, J., S. Tischer, C. Figueiredo, A. Limbourg, C. Falk, S. Immenschuh, R. Blasczyk, and B. Eiz-Vesper. 2012. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(2) T cells. PLoS ONE 7: e51747.
42. Yessoufou, A., A. Plé, K. Moutairou, A. Hichami, and N. A. Khan. 2009. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+ CD25+ regulatory T-cells. J. Lipid Res. 50: 2377-2388.
43. De Taeye, B. M., T. Novitskaya, O. P. McGuinness, L. Gleaves, M. Medda, J. W. Covington, and D. E. Vaughan. 2007. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293: E713-E725. (Pubitemid 47358983)
44. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808. (Pubitemid 38063703)
45. Hotamisligil, G. S. 1999. Mechanisms of TNF-alpha-induced insulin resistance. Exp. Clin. Endocrinol. Diabetes 107: 119-125.
46. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117: 175-184. (Pubitemid 46048464)
47. Lolmède, K., C. Duffaut, A. Zakaroff-Girard, and A. Bouloumié. 2011. Immune cells in adipose tissue: key players in metabolic disorders. Diabetes Metab. 37: 283-290.
48. Schipper, H. S., B. Prakken, E. Kalkhoven, and M. Boes. 2012. Adipose tissueresident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 23: 407-415.
49. Mauer, J., B. Chaurasia, L. Plum, T. Quast, B. Hampel, M. Blüher, W. Kolanus, C. R. Kahn, and J. C. Brüning. 2010. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genet. 6: e1000938.